Researchers Develop Anti-tumor Compounds

News   Nov 09, 2017 | Original story from RUDN University

 
Researchers Develop Anti-tumor Compounds

The structure of the obtained substance is 3,4-diaryl-5-carboxy-4,5-dihydroisoxazole-2-oxide. Credit: Victor Khrustalev

 
 
 

RELATED ARTICLES

Existing 20-year-old Multiple Sclerosis Drug Effective Against Multi-resistant Bacteria

News

A widely-used and twenty-year-old medicine used to treat multiple sclerosis can also beat a type of multi-resistant bacteria for which there are currently only a few effective drugs.

READ MORE

Novel Chemistry Technique Simplifies Late-Stage Modification of Drug Compounds

News

Chemists at The Scripps Research Institute (TSRI) have invented a technique that overcomes a long-standing problem in organic chemistry and should streamline the process of discovery and development for many new drugs.

READ MORE

Advanced Prostate Cancer: EMA Approves Abiraterone Combined With Hormone Therapy as First-line Treatment

News

The prostate cancer drug abiraterone has been approved by the European Medicines Agency in combination with standard hormone therapy for use as a first-line treatment for advanced prostate cancer.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Informatics & Automation

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE